ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 10 of 33
Up
УЖМБС 2021, 6(4): 70–76
https://doi.org/10.26693/jmbs06.04.070
Clinical Medicine

Analysis of Ipsilateral Adrenal Pathology in Patients with Renal Cell Cancer

Balarabe U., Lisova G. V.
Abstract

The purpose of the study was the analysis of the structure of the pathology of the ipsilateral adrenal gland after radical nephrectomy or partial nephrectomy in patients with renal cell cancer. Materials and methods. To study the structure of adrenal pathology in a sample of 2,084 patients who were treated for renal cell cancer, a retrospective study of the pathological findings and case reports of 108 patients, in whom surgical treatment included adrenalectomy or adrenal resection, was performed. Results and discussion. In 10 (83.3%) of 12 patients with adrenal gland resection, mass lesions of this organ served as an indication for adrenal surgery, while in 2 (16.7%) patients intraoperative adrenal trauma was noted. In this group, there were no situations of preservation of the adrenal gland with a direct generalization of the renal tumor to it. Among 98 patients who underwent adrenalectomy, the main indications for removal of the adrenal gland were its mass lesions in 65 (66.3%) cases, while direct tumor generalization to the ipsilateral adrenal gland took place in 8 (8.2%) cases. In other 7 (7.1%) situations, a tumor thrombus penetrated through the lumen of the renal or inferior vena cava into the lumen of the adrenal vein. In 16 (16.7%) patients, adrenalectomy was performed due to massive trauma to the adrenal gland during the removal of massive renal tumors localized in the upper pole of the kidney. Among all 75 patients with mass ipsilateral lesions of the adrenal glands, metastases of renal cell cancer were detected in 12 (16%) cases. In 59 (78.7%) cases benign adrenal adenomas were found, in 2 (2.7%) cases – myelolipomas, in 1 (1.3%) – adrenal hyperplasia, in another 1 (1.3%) – pheochromocytoma. The proportion of synchronous malignant pathology of the ipsilateral adrenal gland in patients with renal cell cancer and with indications for adrenalectomy was 25% (27 out of 108 observations). In relation to all 2,084 operated patients, this indicator did not exceed 1.3%. In the group of organ-preserving surgery, it was significantly lower – 0.2% (2 out of 968 patients), while in the group of radical or cytoreductive nephrectomy it reached 2.2% (25 out of 1116 cases). The total amount of cases of the ipsilateral adrenal gland lesions with renal cell cancer was also studied: 12 (0.6%) – metastases, 8 (0.4%) – direct tumor generalization and 7 (0.3%) – tumor invasion into the adrenal vein, which was determined in 27 (1.3%) patients. Conclusion. The need for ipsilateral adrenalectomy or adrenal resection is extremely rare in the large modern cohort of patients. At the same time, a significant part of the synchronous formations of the ipsilateral adrenal glands is benign tumors. In this regard, further study of the feasibility and safety of adrenal organ-preserving surgeries is necessary

Keywords: renal cell cancer, adrenal metastases, adrenalectomy, adrenal resection

Full text: PDF (Rus) 297K

References
  1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 1969; 101(3): 297-301. https://www.ncbi.nlm.nih.gov/pubmed/5765875. https://doi.org/10.1016/s0022-5347(17)62331-0
  2. Skinner DG, Vermilion CD, Colvin RB. The surgical management of renal cell carcinoma. J Urol. 1972; 107: 705–710. https://www.ncbi.nlm.nih.gov/pubmed/5022527. https://doi.org/10.1016/s0022-5347(17)61121-2
  3. Siemer S, Lehmann J, Kamradt J, Loch T, Remberger K, Humke U, et al. Adrenal metastases in 1635 patients with renal cell carcinoma: outcome and indication for adrenalectomy. J Urol. 2004; 171(6 Pt 1): 2155-9. https://www.ncbi.nlm.nih.gov/pubmed/15126776. https://doi.org/10.1097/01.ju.0000125340.84492.a7
  4. Daza J, Beksac AT, Kannappan M, Chong J, Abaza R, Hemal A, et al. Identifying tumor-related risk factors for simultaneous adrenalectomy in patients with cT1-cT2 kidney cancer during robotic assisted laparoscopic radical nephrectomy. Minerva Urol Nephrol. 2021; 73(1): 72-77. https://www.ncbi.nlm.nih.gov/pubmed/31166101. https://doi.org/10.23736/S0393-2249.19.03440-4
  5. Samuel G, Antoine SG, Pfeifer Z, Carroll AM, Reece B, Lloyd GL. Management of locally advanced renal cell carcinoma. AME Med J. 2021; 6: 5. https://doi.org/10.21037/amj-20-79
  6. Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, et al. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Eur Urol. 2011; 60(3): 458-64. https://www.ncbi.nlm.nih.gov/pubmed/21514718. https://doi.org/10.1016/j.eururo.2011.04.022
  7. Nason GJ, Walsh LG, Redmond CE, Kelly NP, McGuire BB, Sharma V, et al. Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomes. Can Urol Assoc J. 2015; 9(9-10): E583-8. https://www.ncbi.nlm.nih.gov/pubmed/26425218. https://www.ncbi.nlm.nih.gov/pmc/articles/4581922. https://doi.org/10.5489/cuaj.2842
  8. Weight CJ, Mulders PF, Pantuck AJ, Thompson RH. The Role of Adrenalectomy in Renal Cancer. Eur Urol Focus. 2016 Feb; 1(3): 251-257. https://www.ncbi.nlm.nih.gov/pubmed/28723393. https://doi.org/10.1016/j.euf.2015.09.005
  9. Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT. AJR Am J Roentgenol. 2016; 207(5): 1031-1038. https://www.ncbi.nlm.nih.gov/pubmed/27556736. https://doi.org/10.2214/AJR.16.16193
  10. Tu W, Verma R, Krishna S, McInnes MDF, Flood TA, Schieda N. Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT? AJR Am J Roentgenol. 2018; 211(5): 1044-1050. https://www.ncbi.nlm.nih.gov/pubmed/30207794. https://doi.org/10.2214/AJR.17.19276
  11. Kutikov A, Piotrowski ZJ, Canter DJ, Li T, Chen DY, Viterbo R, et al. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011;185(4):1198-203. https://www.ncbi.nlm.nih.gov/pubmed/21334029. https://www.ncbi.nlm.nih.gov/pmc/articles/3117661. https://doi.org/10.1016/j.juro.2010.11.090
  12. Woo S, Cho JY, Kim SY, Kim SH. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques? Acta Radiol. 2014; 55(9): 1120-8. https://www.ncbi.nlm.nih.gov/pubmed/24252816. https://doi.org/10.1177/0284185113512301